The few published data reporting the effect of ciglitazone in cervical cancer cells (C-33 A, C-4II, HeLa) showed either an inhibition of the proliferation or an apoptotic death in a PPARγ-independent manner [34, 35]. The gene discussed is PPARG; the disease is cervical cancer.